Asthma Education: Does it Encourage Asthma Self-management?

Image

Journal of Clinical Immunology and Allergy is a world class open access journal intended to publish the cutting-edge research in the field of Immunology and Allergy.

Journal of Clinical Immunology and Allergy endeavours to publish both basic, fundamental and advanced developmental research in allergy, respiratory diseases, diagnosis, preventive treatment methodologies, New drug development, combinatorial anti allergen, anti-inflammatory and antibacterial drug therapy and research.

Worldwide, thousands of deaths per year are attributed to asthma and there is evidence that most of these deaths are preventable. Despite an overall decrease over the past decade asthma mortality in older adults remain high.

Prompt recognition of symptoms and appropriate medication are key points in treating asthma exacerbations. Patients admitted to hospital may have labile airway obstruction for extended periods following discharge, increasing the risk of readmission. While symptoms are the usual manifestation of exacerbation, and can become severe in a short lapse of time, a decrease in peak expiratory flow (PEF) rate is a useful index of deterioration, especially in low perceivers of obstruction who notice reduced airflow only when it becomes marked.

The rates of optimal asthma control and compliance to treatment are reportedly low. postulated that adults attending emergency department (ED) with asthma exacerbation were not using self-management strategies optimally.

Asthma education intervention:

Pulmonary physicians experienced with asthma education delivered the AEI, which was conceived according to the GINA recommendations

1. Asthma general information

2. Rationale for medications

3. Effective use of inhalers device

4. Adherence to medication

5. Guided asthma self-management

Impacts can be indirect to human health, such as effects on agriculture, disease appearance as well as to economics or even social life.

In order to spread the awareness the journal accepts original manuscripts in the form of Research articles, Review articles, Clinical Reviews, Commentaries, Case Reports, Perspectives and Short Communications encompassing all aspects of Clinical Immunology and Allergy for publication in open access platform.

All the manuscript published by Clinical Immunology and Allergy are available freely online immediately after publication without any subscription charges or registration.

You can Submit your manuscript at :http://www.imedpub.com/submissions/insights-allergy-asthma-bronchitis.html or as an attachment to this

E-mail:clinicalimmuno@clinicalmedicaljournals.com

How we work:

• After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.

• A 21-day window time frame is allotted for peer-review process wherein multiple experts are contacted.

• Author proof is generated within 7 working days after the acceptance decision.

Open Access:

Permanent free access to your article upon publication ensures extensive global reach and readership.

Easy Article Sharing:

Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.

Global Marketing:

Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.

Social Media Exposure:

Extended reach for your article through links on Twitter accounts provides maximum visibility worldwide.

Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.

Media Contact
Sana George
Journal Manage
Clinical Immunology and Allergy
Email: clinicalimmuno@clinicalmedicaljournals.com
WhatsApp: +1-947-333-4405